Is Short-Selling a Risk for Moderna?
Short-sellers have placed bets on the decline of various coronavirus vaccine developers throughout the vaccine race. Short positions were particularly high from July through November of last year. In this Motley Fool Live video recorded on Feb. 26, 2021, healthcare and cannabis bureau chief Corinne Cardina and Fool.com contributor Adria Cimino discuss whether the trend will continue -- or whether investors today are more confident about Moderna (NASDAQ: MRNA) and other vaccine stocks.
Source Fool.com


